These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30940771)

  • 1. 12-month randomised controlled trial of ginseng extract for moderate COPD.
    Shergis JL; Thien F; Worsnop CJ; Lin L; Zhang AL; Wu L; Chen Y; Xu Y; Langton D; Da Costa C; Fong H; Wu D; Story D; Xue CC
    Thorax; 2019 Jun; 74(6):539-545. PubMed ID: 30940771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panax ginseng C.A Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trial.
    Xue CC; Shergis JL; Zhang AL; Worsnop C; Fong H; Story D; Da Costa C; Thien FC
    Trials; 2011 Jun; 12():164. PubMed ID: 21718484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial.
    Chen Y; Lin L; Wu L; Xu Y; Shergis JL; Zhang AL; Wen Z; Worsnop C; Da Costa C; Thien F; Xue CC
    Int J Chron Obstruct Pulmon Dis; 2020; 15():671-680. PubMed ID: 32273696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study.
    LaForce C; Feldman G; Spangenthal S; Eckert JH; Henley M; Patalano F; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1233-43. PubMed ID: 27354782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
    Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
    Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review.
    An X; Zhang AL; Yang AW; Lin L; Wu D; Guo X; Shergis JL; Thien FC; Worsnop CJ; Xue CC
    Respir Med; 2011 Feb; 105(2):165-76. PubMed ID: 21146973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial.
    Braz AS; Morais LC; Paula AP; Diniz MF; Almeida RN
    Braz J Psychiatry; 2013 Mar; 35(1):21-8. PubMed ID: 23567596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.
    Kim CJ; Yoon HK; Park MJ; Yoo KH; Jung KS; Park JW; Lim SY; Shim JJ; Lee YC; Kim YS; Oh YM; Kim S; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1589-1596. PubMed ID: 28615931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
    Goudie AR; Lipworth BJ; Hopkinson PJ; Wei L; Struthers AD
    Lancet Respir Med; 2014 Apr; 2(4):293-300. PubMed ID: 24717626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot study.
    Wu L; Zhang AL; Di YM; Shergis JL; Chen Y; Guo X; Wen Z; Thien F; Worsnop C; Lin L; Xue CC
    Chin Med; 2014; 9():20. PubMed ID: 25161696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2003 May; 58(5):399-404. PubMed ID: 12728159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
    Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease.
    Brockwell C; Ampikaipakan S; Sexton DW; Price D; Freeman D; Thomas M; Ali M; Wilson AM
    Int J Chron Obstruct Pulmon Dis; 2014; 9():715-21. PubMed ID: 25031533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD.
    Matthys H; Pliskevich DA; Bondarchuk OM; Malek FA; Tribanek M; Kieser M
    Respir Med; 2013 May; 107(5):691-701. PubMed ID: 23478193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trial.
    Magnussen H; Watz H; Kirsten A; Wang M; Wray H; Samuelsson V; Mo J; Kay R
    Pulm Pharmacol Ther; 2011 Oct; 24(5):563-70. PubMed ID: 21624491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginseng improves pulmonary functions and exercise capacity in patients with COPD.
    Gross D; Shenkman Z; Bleiberg B; Dayan M; Gittelson M; Efrat R
    Monaldi Arch Chest Dis; 2002; 57(5-6):242-6. PubMed ID: 12814035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
    Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S
    Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial.
    Liang J; Abramson MJ; Zwar N; Russell G; Holland AE; Bonevski B; Mahal A; Hecke BV; Phillips K; Eustace P; Paul E; Petrie K; Wilson S; George J
    BMJ Open; 2017 Sep; 7(9):e016985. PubMed ID: 28928190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.